Ordinary Adjustment | European Biotech Index (Net Return) (EUR) | Effective Date 9th April 2024
European Biotech Index (Net Return) (EUR):
In the ordinary adjustment, the following composition will be implemented over a period starting on 2nd April 2024 cob and ending on 8th April 2024 cob. The new composition will be fully reflected in the index with effective open 9th April 2024:
| GENUS PLC |
| OXFORD INSTRUMENTS PLC |
| BIONTECH SE |
| MORPHOSYS AG |
| BAVARIAN NORDIC A/S |
| EVOTEC SE |
| VALNEVA SE |
| HIKMA PHARMACEUTICALS PLC |
| ORION OYJ CLASS B |
| SWEDISH ORPHAN BIOVITRUM AB |
| CHEMOMETEC A/S |
| BIOTAGE AB |
| GERRESHEIMER AG |
| ALMIRALL SA |
| LABORATORIOS FARMACEUTICOS R |
| PHARMING GROUP NV |
| DERMAPHARM HOLDING SE |
| VITROLIFE AB |
| BICO AB |
| EL.EN. S.P.A. |
| PHARMA MAR SA |
| EUROFINS SCIENTIFIC SE |
| ALK-ABELLO A/S |
| OXFORD NANOPORE TECHNOLOGIES PLC |
| GRIFOLS SA CLASS A |
| AVACTA GROUP PLC |